Concepedia

Publication | Open Access

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

DOIFull Paper Access

38

Citations

36

References

2021

Year

Keisuke Koroki, Naoya Kanogawa, Susumu Maruta, Sadahisa Ogasawara, Yotaro Iino, Masamichi Obu, Tomomi Okubo, Norio Itokawa, Takahiro Maeda, Masanori Inoue,
Liver Cancer

Abstract

Sorafenib may not be a candidate for use as a posttreatment agent after lenvatinib, according to the results of the present study. Regorafenib has the potential to become an appropriate posttreatment agent after lenvatinib.

References

YearCitations

Page 1